| |
| |
|
| Insider
Information: |
Oconnell Maureen |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
288,225 |
|
|
Indirect Shares
|
40,650 |
|
|
| Direct
Value |
$2,614,660 |
|
|
|
Indirect Value
|
$1,480,473 |
|
|
| Total
Shares |
328,875 |
|
|
| Total
Value |
$4,095,133 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 44.8%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Scholastic Corp |
SCHL |
EVP, CAO & CFO |
2017-09-25 |
31,121 |
2016-12-19 |
40,650 |
Premium* |
|
|
Sucampo Pharmaceuticals, Inc. |
SCMP |
Director |
2018-02-13 |
0 |
2016-06-02 |
0 |
Premium* |
|
|
Harte-Hanks Inc |
HHS |
Director |
2020-07-22 |
29,971 |
2018-07-27 |
0 |
Premium* |
|
|
Acacia Research Corp |
ACTG |
Director |
2023-05-26 |
217,310 |
2019-05-08 |
0 |
Premium* |
|
|
Rev Group, Inc. |
REVG |
Director |
2023-12-08 |
9,823 |
2023-08-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REVG |
Rev Group, Inc. |
Director |
– • – |
2023-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
7,084 |
9,823 |
0 |
- |
|
| REVG |
Rev Group, Inc. |
Director |
– • – |
2023-08-25 |
4 |
A |
$0.00 |
$0 |
D/D |
2,739 |
2,739 |
0 |
- |
|
| ACTG |
Acacia Research Corp |
Director |
– • – |
2023-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
30,534 |
217,310 |
0 |
- |
|
| ACTG |
Acacia Research Corp |
Director |
– • – |
2022-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
26,201 |
186,776 |
0 |
- |
|
| ACTG |
Acacia Research Corp |
Director |
– • – |
2021-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
21,661 |
160,575 |
0 |
- |
|
| ACTG |
Acacia Research Corp |
Director |
– • – |
2020-09-08 |
4 |
B |
$3.77 |
$50,845 |
D/D |
13,470 |
138,914 |
2.39 |
% |
|
| ACTG |
Acacia Research Corp |
Director |
– • – |
2020-09-04 |
4 |
B |
$3.78 |
$43,631 |
D/D |
11,530 |
125,444 |
2.39 |
% |
|
| HHS |
Harte-Hanks Inc |
Director |
• • – |
2020-07-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,557 |
29,971 |
0 |
- |
|
| ACTG |
Acacia Research Corp |
Director |
– • – |
2020-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
48,000 |
113,914 |
0 |
- |
|
| HHS |
Harte-Hanks Inc |
Director |
• • – |
2020-03-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,136 |
25,414 |
0 |
- |
|
| ACTG |
Acacia Research Corp |
Director |
– • – |
2019-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
43,478 |
65,914 |
0 |
- |
|
| ACTG |
Acacia Research Corp |
Director |
– • – |
2019-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
22,436 |
22,436 |
0 |
- |
|
| HHS |
Harte-Hanks Inc |
Director |
– • – |
2019-03-21 |
4 |
A |
$0.00 |
$0 |
D/D |
23,136 |
29,971 |
0 |
- |
|
| HHS |
Harte-Hanks Inc |
Director |
– • – |
2018-07-27 |
4 |
A |
$0.00 |
$0 |
D/D |
6,835 |
6,835 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
Director |
– • – |
2018-02-13 |
4 |
D |
$18.00 |
$92,340 |
D/D |
(5,130) |
0 |
0 |
- |
|
| SCHL |
Scholastic Corp |
EVP, CAO & CFO |
• – – |
2017-09-25 |
4 |
D |
$36.28 |
$29,024 |
D/D |
(800) |
31,121 |
0 |
- |
|
| SCHL |
Scholastic Corp |
EVP, CAO & CFO |
• – – |
2017-09-21 |
4 |
D |
$35.17 |
$21,876 |
D/D |
(622) |
31,921 |
0 |
- |
|
| SCHL |
Scholastic Corp |
EVP, CAO & CFO |
• – – |
2017-09-20 |
4 |
D |
$38.61 |
$26,718 |
D/D |
(692) |
32,543 |
0 |
- |
|
| SCHL |
Scholastic Corp |
EVP, CAO & CFO |
• – – |
2017-09-19 |
4 |
A |
$38.60 |
$209,984 |
D/D |
5,440 |
33,235 |
0 |
- |
|
| SCHL |
Scholastic Corp |
EVP, CAO & CFO |
• – – |
2017-09-18 |
4 |
D |
$39.04 |
$35,058 |
D/D |
(898) |
27,795 |
0 |
- |
|
| SCHL |
Scholastic Corp |
EVP, CAO & CFO |
• – – |
2017-09-05 |
4 |
OE |
$39.34 |
$197,802 |
D/D |
5,028 |
31,168 |
0 |
- |
|
| SCHL |
Scholastic Corp |
EVP, CAO & CFO |
• – – |
2017-09-05 |
4 |
D |
$39.34 |
$97,367 |
D/D |
(2,475) |
28,693 |
0 |
- |
|
| SCHL |
Scholastic Corp |
EVP, CAO & CFO |
• – – |
2017-08-03 |
4 |
D |
$40.64 |
$70,104 |
D/D |
(1,725) |
26,140 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
Director |
– • – |
2017-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,130 |
14,930 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
Director |
– • – |
2017-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,130 |
14,930 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
